The Hedge Funds Behind the Biopharma IPO Bonanza

Perceptive, RA Capital and RTW are among hedge fund firms with stakes in biopharma companies preparing to go public.

Stephen Taub January 21, 2021

Michael Nagle/Bloomberg

The market for initial public offerings has picked up where it left off in 2020. Red hot.And many hedge funds are eager to cash in, especially in the booming biopharma and health-care-related sectors. In the past week or so, at least five companies whose major

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

develop build:2025-12-18 Login